The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This study has been designed to investigate the effect of lersivirine on the QT/QTc interval
in order to help establish the safety profile of lersivirine.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Moxifloxacin Norgestimate, ethinyl estradiol drug combination